发明名称 Protein involved in ovarian cancer
摘要 The present invention relates to new uses of CDCP1 in the diagnosis, screening, treatment and prophylaxis of ovarian cancer. The invention also provides compositions comprising CDCP1, including vaccines, antibodies that are immunospecific for CDCP1 and agents which interact with or modulate the expression or activity of CDCP1 or which modulate the expression of the nucleic acid which codes for CDCP1.
申请公布号 US9120860(B2) 申请公布日期 2015.09.01
申请号 US201213566011 申请日期 2012.08.03
申请人 UCB Pharma S.A. 发明人 Burgess Nicola Anne
分类号 G01N33/574;G01N33/53;C07K16/30;A61K38/17;C12Q1/68;G01N33/68 主分类号 G01N33/574
代理机构 Klauber & Jackson LLC 代理人 Klauber & Jackson LLC
主权项 1. A method of screening for and/or diagnosis or prognosis of ovarian cancer in a human female subject, and/or monitoring the effectiveness of ovarian cancer therapy, which comprises the steps of (a) detecting and/or quantifying in an ovarian tissue sample obtained from said subject, the expression of a CDCP 1 polypeptide using an immunoassay; and (b) comparing the level of expression of CDCP 1 in the sample with a previously determined reference range or control.
地址 Brussels BE